1. Home
  2. KRMD vs BWAY Comparison

KRMD vs BWAY Comparison

Compare KRMD & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

HOLD

Current Price

$5.80

Market Cap

186.3M

Sector

Health Care

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$17.10

Market Cap

337.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRMD
BWAY
Founded
1980
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
186.3M
337.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
KRMD
BWAY
Price
$5.80
$17.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$5.13
$23.50
AVG Volume (30 Days)
185.4K
61.8K
Earning Date
11-12-2025
11-11-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
213.09
EPS
N/A
0.13
Revenue
$39,070,637.00
$49,094,000.00
Revenue This Year
$23.36
$330.76
Revenue Next Year
$18.63
$22.24
P/E Ratio
N/A
$51.80
Revenue Growth
22.12
27.08
52 Week Low
$1.86
$7.84
52 Week High
$6.11
$18.18

Technical Indicators

Market Signals
Indicator
KRMD
BWAY
Relative Strength Index (RSI) 64.27 54.19
Support Level $5.44 $15.97
Resistance Level $5.88 $17.38
Average True Range (ATR) 0.35 0.68
MACD -0.05 -0.10
Stochastic Oscillator 76.25 51.25

Price Performance

Historical Comparison
KRMD
BWAY

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: